Classification and Personalized Prognosis in Myeloproliferative Neoplasms. (2018)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1716614
PubMed Identifier: 30304655
Publication URI: http://europepmc.org/abstract/MED/30304655
Type: Journal Article/Review
Volume: 379
Parent Publication: The New England journal of medicine
Issue: 15
ISSN: 0028-4793